Carreira Delgado, Patricia Esmeralda
Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study. [artículo] Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis - The Journal of rheumatology, 2014 - 41(1):99-105.
Formato Vancouver:
Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA et al. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol. 2014 Jan;41(1):99-105.
PMID: 24293584
Contiene 30 referencias
Objective. To estimate the prevalence, determine the subgroups at risk, and the outcomes of patients with systemic sclerosis (SSc) and gastric antral vascular ectasia (GAVE). Methods. We queried the European League Against Rheumatism Scleroderma Trials and Research (EUSTAR) network for the recruitment of patients with SSc-GAVE. Each case was matched for cutaneous subset and disease duration with 2 controls with SSc recruited from the same center, evaluated at the time the index case made the diagnosis of GAVE. SSc characteristics were recorded at the time GAVE occurred and the last observation was collected to define the outcomes.
Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study. [artículo] Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis - The Journal of rheumatology, 2014 - 41(1):99-105.
Formato Vancouver:
Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA et al. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol. 2014 Jan;41(1):99-105.
PMID: 24293584
Contiene 30 referencias
Objective. To estimate the prevalence, determine the subgroups at risk, and the outcomes of patients with systemic sclerosis (SSc) and gastric antral vascular ectasia (GAVE). Methods. We queried the European League Against Rheumatism Scleroderma Trials and Research (EUSTAR) network for the recruitment of patients with SSc-GAVE. Each case was matched for cutaneous subset and disease duration with 2 controls with SSc recruited from the same center, evaluated at the time the index case made the diagnosis of GAVE. SSc characteristics were recorded at the time GAVE occurred and the last observation was collected to define the outcomes.
